General Electric, the US conglomerate, on Thursday unveiled a strategy for its healthcare division designed to cut the costs and extend the sales of its diagnostics equipment around the world.

Its “Healthymagination” programme commits the company to invest $6bn by 2015 to “lower cost, increase access and improve quality” by 15 per cent, with greater emphasis on demonstrating and delivering the value of its products.